Heraeus Medical Components has announced the opening of its Medical Materials Development and Production Center in Singapore to support expansion of its regional R&D activities and production of materials and components. The company is following its customers in the cardiac rhythm management space, many of whom are relocating production to Southeast Asia, explained Nicolas Guggenheim, President, Heraeus Medical Components Div. “With the strong Asian investment in local startups, a strong base of new Asian medical device companies is growing in the region, which makes for a powerful mix of companies and innovation,” he added in a press release issued by the company. Heraeus, headquartered in Hanau, Germany, now operates more than 20 manufacturing facilities in Asia.
The prospect of more transparent regulatory procedures in the region also is prompting more medical device manufacturers to consider setting up facilities in Southeast Asia. The Association of Southeast Asian Nations (ASEAN), a regional economic group representing 10 Southeast Asian nations, plans to implement a single, harmonised regulatory framework for medical devices by late 2014, creating a more efficient medical device market with some 600 million people within its boundaries, notes Bryan Gilburg of Emergo Group. To learn more about regulatory developments in the region and the impact they may have on the medtech industry, read Gilburg’s article, “Single Regulatory Framework Looms for Southeast Asia.”Norbert Sparrow